IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Jun 2002 (Vol: 2002, Issue: 25)

Next Issue >>

Download pdf of entire issue

Section: Company Profile
Takeda Chemical Industries, Ltd. Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Biovail acquires Vasotec®/Vaseretic® from Merck & Co. Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Teva-Tuteur to market Immunomedics’ diagnostic products in Latin America Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Section: General
Major Pharma is Paying Top Dollar for Late Stage Products to Bolster Flagging Pipelines Published: 2 Jun-2002
By: Business Review Editor
Abstract
Deal Making in the Pharmaceutical Fine Chemical Industry Published: 2 Jun-2002
By: Business Review Editor
Abstract
Therapy Focus: Diabetes Published: 2 Jun-2002
By: Business Review Editor
Abstract
Section: Licensing
Medarex acquires technology and antibody product development programmes from Corixa Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Pfizer terminates pagoclone agreement with Indevus Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
GSK licenses oral insulin from Nobex Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Degussa AG divests pharmaceutical interests Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Berna Biotech acquires Rhein Biotech for US$257 M Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Vernalis & Roche enter new collaboration in depression and anxiety Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:
Arena in research collaboration with Ferring Published: 2 Jun-2002
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in